Sodium 18F-Fluoride Bone Scintigraphy in Deep Ocean Diver

被引:1
作者
Lim, Jin T. E. [1 ]
Moncayo, Valeria M. [1 ]
Alazraki, Naomi [1 ,2 ]
机构
[1] Emory Univ, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA
[2] Vet Affairs Med Ctr, Nucl Med Serv, Atlanta, GA 30033 USA
关键词
METASTASES; INFARCT;
D O I
10.1097/RLU.0000000000000801
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Sodium F-18-fluoride (NaF) is a diagnostic marker for new bone formation in bone scintigraphy that was approved by US FDA in 1972 but discontinued in 1984. We report a case of a US naval officer who spent time living and working in an oceanic lab, 205 feet below the surface. Plain skeletal films of femurs 4 years later demonstrate bilateral bone infarcts. Corresponding sodium F-18-fluoride bone scintigraphy demonstrates low-normal to decreased tracer activity. This rectilinear scan image is of historical interest. Other bone scintigraphic radiotracers used in the past and present will be briefly discussed.
引用
收藏
页码:582 / 584
页数:3
相关论文
共 39 条
[1]   Sodium 18F-Fluoride PET/CT of Bone, Joint, and Other Disorders [J].
Jadvar, Hossein ;
Desai, Bhushan ;
Conti, Peter S. .
SEMINARS IN NUCLEAR MEDICINE, 2015, 45 (01) :58-65
[2]   SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0 [J].
Segall, George ;
Delbeke, Dominique ;
Stabin, Michael G. ;
Even-Sapir, Einat ;
Fair, Joanna ;
Sajdak, Rebecca ;
Smith, Gary T. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11) :1813-1820
[3]   Assessment of malignant skeletal disease:: Initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT [J].
Even-Sapir, E ;
Metser, U ;
Flusser, G ;
Zuriel, L ;
Kollender, Y ;
Lerman, H ;
Lievshitz, G ;
Ron, I ;
Mishani, E .
JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (02) :272-278
[4]   Bone scanning with sodium 18F-fluoride PET and PET/CT - German guideline Version 1.0 [J].
Hellwig, D. ;
Krause, B. -J. ;
Schirrmeister, H. ;
Freesmeyer, M. .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2010, 49 (05) :195-201
[5]   18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers [J].
Withofs, Nadia ;
Grayet, Benjamin ;
Tancredi, Tino ;
Rorive, Andree ;
Mella, Christine ;
Giacomelli, Fabrice ;
Mievis, Frederic ;
Aerts, Joel ;
Waltregny, David ;
Jerusalem, Guy ;
Hustinx, Roland .
NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (03) :168-176
[6]   Effect of Erythropoietin on Bone Marrow Uptake of 18F-Fluorocholine in Prostate Cancer Comparison With 18F-Fluoride Uptake [J].
Balogova, Sona ;
Huchet, Virginie ;
Egrot, Christoph ;
Michaud, Laure ;
Paycha, F. ;
Kerrou, Khaldoun ;
Montravers, Francoise ;
Cussenot, Olivier ;
Talbot, Jean Noel .
CLINICAL NUCLEAR MEDICINE, 2013, 38 (03) :200-202
[7]   Quantification of 18F-Fluoride Kinetics: Evaluation of Simplified Methods [J].
Raijmakers, Pieter ;
Temmerman, Olivier P. P. ;
Saridin, Carrol P. ;
Heyligers, Ide C. ;
Becking, Alfred G. ;
van Lingen, Arthur ;
Lammertsma, Adriaan A. .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (07) :1122-1127
[8]   Current status of the use of 18F-sodium fluoride in bone disease [J].
de Arcocha, M. ;
Portilla-Quattrociocchi, H. ;
Medina-Quiroz, P. ;
Carril, J. M. .
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2012, 31 (01) :51-57
[9]   SUV Normalized by Skeletal Volume on 18F-Fluoride PET/CT Studies [J].
Carvalho, Giovanna ;
Gomes Marin, Jose Flavio ;
Garcez, Alexandre Teles ;
Duarte, Paulo Schiavom ;
Sapienza, Marcelo Tatit ;
Buchpiguel, Carlos Alberto .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) :529-533
[10]   Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18F-Fluoride PET/CT Bone Scans [J].
Chen, Chao-Jung ;
Ma, Shih-Ya .
SCIENTIFIC WORLD JOURNAL, 2012,